Jushi Holdings (JUSHF) Cash from Operations (2021 - 2026)
Jushi Holdings (JUSHF) posted quarterly Cash from Operations of 793000.0 for Q2 2026, up 140.98% year-over-year from 329070.34 in Q2 2025, and down 90.79% quarter-over-quarter from 8612000.0 in Q1 2026.
Jushi Holdings (JUSHF) Cash from Operations (2021 - 2026) Analysis & Trends
Jushi Holdings (JUSHF) has reported Cash from Operations for 6 consecutive years, with 793000.0 the latest figure, recorded in Q2 2026.
- In Q2 2026, Cash from Operations rose 140.98% year-over-year to 793000.0; the TTM figure through Jun 2026 stood at 21536000.0 (up 42.42% YoY), while the FY2025 annual figure was 17725000.0, down 17.82% from the prior year.
- Cash from Operations retreated to 793000.0 in Q2 2026 per JUSHF's latest filing, from 8612000.0 in the prior quarter.
- Across five years, Cash from Operations topped out at 8612000.0 in Q1 2026 and bottomed at 13825000.0 in Q1 2022.
- Historically, Cash from Operations has averaged 1331388.89 across 5 years, with a median of 3483500.0 in 2023.
- Annual changes were most pronounced in 2023 — Cash from Operations soared 603.69% — and 2025, when it slumped 134.88%.
- Jushi Holdings' Cash from Operations stood at 4783000.0 in 2022, then fell by 5.73% to 4509000.0 in 2023, then soared by 58.66% to 7154000.0 in 2024, then declined by 15.42% to 6051000.0 in 2025, then plunged by 86.89% to 793000.0 in 2026.
- Business Quant data shows JUSHF's Cash from Operations at 793000.0 in Q2 2026, 8612000.0 in Q1 2026, and 6051000.0 in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Ops. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 411.00 Mn |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | 655.00 Mn |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 800.69 Mn |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | 313.60 Mn |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | 381.80 Mn |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 136.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 277.00 Mn |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Jushi Holdings | 83.87 Mn | 50.54 Mn | 31.53 Mn | 793,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 793,000.00 |
| Jun 30, 2026 | 793,000.00 |
| Mar 31, 2026 | 8.61 Mn |
| Mar 31, 2026 | 8.61 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Dec 31, 2025 | 6.05 Mn |
| Sep 30, 2025 | 6.08 Mn |
| Sep 30, 2025 | 6.08 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Jun 30, 2025 | -1.94 Mn |
| Mar 31, 2025 | 7.53 Mn |
| Mar 31, 2025 | 7.53 Mn |
| Dec 31, 2024 | 7.15 Mn |
| Dec 31, 2024 | 7.15 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Sep 30, 2024 | 2.37 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Jun 30, 2024 | 5.55 Mn |
| Mar 31, 2024 | 6.49 Mn |
| Mar 31, 2024 | 6.49 Mn |